002826.SZ

Tibet AIM Pharm. Inc. [002826.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

002826.SZ Stock Summary

Top 10 Correlated Stocks

002826.SZ

In the News

002826.SZ Financial details

Company Rating
-
Market Cap
1.61B
Income
46.78M
Revenue
803.27M
Book val./share
-
Cash/share
-
Dividend
0.1
Dividend %
0.86%
Employees
447
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
49.29
Forward P/E
-
PEG
42.86
P/S
2.76
P/B
3.06
P/C
-
P/FCF
29.43
Quick Ratio
2.15
Current Ratio
2.4
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.25
EPS next Y
-
EPS next Q
-
EPS this Y
4.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.09%
Revenue last 5Y
11.88%
Revenue Q/Q
-21.04%
EPS Q/Q
71.33%
-
-
-
-
SMA20
-5.41%
SMA50
8.52%
SMA100
-0.3%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
6%
ROC
0.07%
Gross Margin
47%
Oper. Margin
7%
Profit Margin
6%
Payout
44%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.57-13.28
52W High
+54.77%
52W Low
+302.4%
RSI
48.76
Rel Volume
0.48
Avg Volume
6.61M
Volume
3.15M
Perf Week
3.55%
Perf Month
-0.89%
Perf Quarter
-
Perf Half Y
6.12%
-
-
-
-
Beta
0.312
-
-
Volatility
0.28%, 0.88%
Prev Close
0.6%
Price
20.12
Change
-1.9%

002826.SZ Financial Performance

002826.SZ Dividend History

002826.SZ Frequently Asked Questions

What is Tibet AIM Pharm. Inc. stock symbol ?

Tibet AIM Pharm. Inc. is a CN stock and trading under the symbol 002826.SZ

What is Tibet AIM Pharm. Inc. stock quote today ?

Tibet AIM Pharm. Inc. stock price is $20.12 today.

Is Tibet AIM Pharm. Inc. stock public?

Yes, Tibet AIM Pharm. Inc. is a publicly traded company.

Something similar

Top by Market Cap
DHR-PB
JPM
AMZ.DE
AVGO
GOOGL
Same Sector
AGEN
004720.KS
TOI
BOTHE.BR
2929.T
Top Correlated Stocks
002556.SZ
002299.SZ
600300.SS
605365.SS
000928.SZ
Similar Market Cap
002968.SZ
MGNS.L
1528.TW
FCONSUMER.NS
HBM.DE

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 6.61M
  • Market Capitalization 1.61B
  • Employee 447
  • CEO Mr. Ke Xu
  • Headquarters Beijing,CN
  • IPO Date 2016-12-12
  • Website https://www.emyy.cn

Tibet AIM Pharm. Inc. engages in the research and development of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain; Carbetocin injections; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotic, antiallergic, and digestive system. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.